Lefteris Floros

Lefteris Floros is a seasoned health economist with extensive experience in economic analysis and modeling for pharmaceutical market access and reimbursement. Currently serving as the Global HTA Project Manager at MSD Switzerland since February 2021, Lefteris previously held senior roles at PHMR as Principal and Senior Health Economist, consulting for pharmaceutical companies. Additional experience includes a consultancy position at Covance Market Access and a Health Economist role at the National Clinical Guideline Centre, where contributions enhanced NICE clinical guidelines. Previous positions also include support for the economic aspects of research applications at the National Institute for Health Research. Lefteris holds an MSc in International Health Management from Imperial College London and a BSc in Economics from Aristotle University of Thessaloniki, along with several specialized training courses in health economics.